Aligos Therapeutics (ALGS) Cash & Current Investments (2019 - 2026)
Aligos Therapeutics (ALGS) recorded Cash & Current Investments of $30.4 million in Q2 2026, down 75.3% from $122.9 million a year earlier and down 44.6% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics reported Cash & Current Investments of $77.8 million, up 36.7% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $56.9 million in FY2024 (-58.1%), $135.7 million in FY2023 (+7.9%), $125.8 million in FY2022 (-38.9%) and $205.8 million in FY2021 (-15.5%).
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q2 2020.
- On a year-over-year basis, Cash & Current Investments rose in five of the last eight quarters, with an average decline of 8.2%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 662.8% in Q3 2021, against a decline of 75.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $54.9 million (Q1 2026), $77.8 million (Q4 2025) and $99.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,127.89 Bn | 1,096.47 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.11 Bn | 554.97 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.80 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.24 Bn | 312.62 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 290.13 Bn | 254.12 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.87 Bn | 193.27 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.91 Bn | 169.11 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Aligos Therapeutics | 50.43 Mn | -277.97 Mn | - | 30.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.40 Mn |
| Mar 31, 2026 | 54.90 Mn |
| Dec 31, 2025 | 77.80 Mn |
| Sep 30, 2025 | 99.10 Mn |
| Jun 30, 2025 | 122.90 Mn |
| Mar 31, 2025 | 137.90 Mn |
| Dec 31, 2024 | 56.90 Mn |
| Sep 30, 2024 | 74.90 Mn |
| Jun 30, 2024 | 94.50 Mn |
| Mar 31, 2024 | 112.70 Mn |
| Dec 31, 2023 | 135.70 Mn |
| Sep 30, 2023 | 70.40 Mn |
| Jun 30, 2023 | 90.80 Mn |
| Mar 31, 2023 | 103.50 Mn |
| Dec 31, 2022 | 125.80 Mn |
| Sep 30, 2022 | 142.30 Mn |
| Jun 30, 2022 | 159.30 Mn |
| Mar 31, 2022 | 183.20 Mn |
| Dec 31, 2021 | 205.80 Mn |
| Sep 30, 2021 | 242.70 Mn |
API Access
Aligos Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();